Ubrelvy 100 MG tablet UD 16S
Ended Awarded Last action
- Contract number
- SPE2DR26FA0LW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,251
Award facts
- Contract value 100% obligated
- $42,250.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $42,250.59 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (16 unit dose packages) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
UBRELVY, a migraine treatment medication, represents one of many specialty pharmaceuticals that AmerisourceBergen delivers through its DLA contracts to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contractor's extensive portfolio demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order exemplifies the operational flexibility of the broader pharmaceutical prime vendor contract vehicle, which DLA has structured to support diverse military healthcare needs worldwide.
Quick answers
Who was awarded contract SPE2DR26FA0LW?
SPE2DR26FA0LW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FA0LW worth?
The government has obligated $42,251 on SPE2DR26FA0LW.
Is contract SPE2DR26FA0LW an order under another contract?
Yes. SPE2DR26FA0LW is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0LW competed?
The extent of competition for SPE2DR26FA0LW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award